Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 62.00
+0.60 (0.98%)
Oct 8, 2026, 1:30 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 20.38 billion as of October 8, 2026. It is the 13,176th most valuable company in the world and the 446th biggest in Taiwan. Its market cap has increased by 59.59% in one year.
Market Cap
20.38B
Enterprise Value
19.45B
Revenue
573.85M
Global Rank
Country Rank
#446 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 20.38B, an increase of 618.96%. That is a compound annual growth rate of 19.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 20.38B | 64.24% |
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 25.79B |
| Oneness Biotech | 22.58B |
| Sunmax Biotechnology | 21.51B |
| Steminent Biotherapeutics | 17.36B |
| TaiMed Biologics | 16.39B |
| Ever Supreme Bio Technology | 16.12B |
| Gongwin Biopharm Holdings | 15.44B |
| EirGenix | 15.14B |